GlassScriptPhysician profile
Troy Michael Sofinowski
NPI 1053517359
$3,813.53
in general payments reported to CMS, 2019-2025
11 companies · $3,470 in 2025
The $3,470 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $125 · 2021: $54.62 · 2022: $48.98 · 2025: $3,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,886 · Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,885.87 |
| Food and Beverage | $584.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,497.93 | 2019-2025 | Lumenis Pulse 120h, General - Kidney Stone Disease, General - Bph |
| Procept Biorobotics Corporation | $161.09 | 2025 | |
| Astellas Pharma US INC | $25.77 | 2020-2025 | Xtandi |
| Endo Pharmaceuticals INC. | $23.44 | 2019 | |
| Endo USA, INC. | $18.09 | 2025 | Edex, Xiaflex, Aveed |
| Teleflex LLC | $17.02 | 2025 | Barrigel |
| Antares Pharma, INC. | $16.14 | 2025 | Xyosted |
| Janssen Biotech, INC. | $16.08 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.40 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $12.39 | 2019 | |
| Abbvie INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Sofinowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.